TORONTO, ON / ACCESSWIRE / March 24, 2022 / AI/ML Innovations Inc. (AIML: CSE)(AIMLF: OTCQB)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has completed a non-brokered private placement offering (the "Offering") to identified strategic health technology investors of 4,000,000 units ("Units") at $0.15 per Unit for gross proceeds of $600,000. Each Unit is comprised of one common share and one share purchase warrant, with each warrant having an exercise price of $0.20 and an expiration date of 12 months from the date of issuance, subject to acceleration if AIML trades at $0.30 for 10 consecutive trading days. The Company intends to use the proceeds of this offering to further advance its platform deployment with key healthcare clients as well as general operating capital. The Company paid finder's fees of $25,337.81 in respect to the Offering. For more information about AI/ML Innovations: For detailed information please see AI/ML's website at https://aiml-innovations.com/ or the Company's filed documents at www.sedar.com Presentations: Investor slidedeck: https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ A picture containing textDescription automatically generated About AI/ML Innovations Inc.https://aiml-innovations.com/ AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB". On behalf of the Board of Directors Tim Daniels, Executive Chairman THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL. For more information about AI/ML Innovations: For detailed information please visit our website or our filed documents at www.sedar.com Presentations: Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. SOURCE: AI/ML Innovations Inc. https://www.accesswire.com/694599/AIML-Innovations-Inc-Completes-Financing-for-Total-Gross-Proceeds-of-60000000